Drug Pipeline

JNJ-87801493 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07308132 A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies Lymphoma, Non-Hodgkin Recruiting
NCT06139406 A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell… Lymphoma, Non-Hodgkin Active, Not Recruiting
NCT06788509 A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring Leukemia, Myeloid, Acute Enrolling by Invitation
Sponsors Running JNJ-87801493 Trials
Janssen Research & Development, LLC (3)
Disease Areas
Leukemia (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when JNJ-87801493 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free